In our previous study, we demonstrated a miR‐204/HMGA2 axis which can modulate CRC cell chemoresistance to 5‐FU‐based chemotherapy.5 Herein, we also validated that PCAT6 knockdown could reduce HMGA2 protein level. The gene discussed is HMGA2; the disease is colorectal carcinoma.